Abstract

The invention consists of a method to activate cyclic AMP (cAMP)-mediated intracellular response in renal cells by triggering the beta-3 subtype adrenergic receptor (BAR3).

Research Institution

Università di Pisa

Numero di pubblicazione

WO2016046763A1

TRL

n.a.

Technologies, Systems, Applications

Biotechnologies, New drugs development